1. Home
  2. BLCO vs ESNT Comparison

BLCO vs ESNT Comparison

Compare BLCO & ESNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • ESNT
  • Stock Information
  • Founded
  • BLCO 1853
  • ESNT 2008
  • Country
  • BLCO Canada
  • ESNT Bermuda
  • Employees
  • BLCO N/A
  • ESNT N/A
  • Industry
  • BLCO Ophthalmic Goods
  • ESNT Property-Casualty Insurers
  • Sector
  • BLCO Health Care
  • ESNT Finance
  • Exchange
  • BLCO Nasdaq
  • ESNT Nasdaq
  • Market Cap
  • BLCO 7.0B
  • ESNT 5.9B
  • IPO Year
  • BLCO 2022
  • ESNT 2013
  • Fundamental
  • Price
  • BLCO $18.02
  • ESNT $53.32
  • Analyst Decision
  • BLCO Buy
  • ESNT Buy
  • Analyst Count
  • BLCO 12
  • ESNT 7
  • Target Price
  • BLCO $20.91
  • ESNT $64.71
  • AVG Volume (30 Days)
  • BLCO 524.8K
  • ESNT 756.3K
  • Earning Date
  • BLCO 10-30-2024
  • ESNT 02-07-2025
  • Dividend Yield
  • BLCO N/A
  • ESNT 2.10%
  • EPS Growth
  • BLCO N/A
  • ESNT 10.79
  • EPS
  • BLCO N/A
  • ESNT 6.90
  • Revenue
  • BLCO $4,684,000,000.00
  • ESNT $1,184,351,000.00
  • Revenue This Year
  • BLCO $17.39
  • ESNT N/A
  • Revenue Next Year
  • BLCO $6.18
  • ESNT $4.81
  • P/E Ratio
  • BLCO N/A
  • ESNT $7.72
  • Revenue Growth
  • BLCO 18.01
  • ESNT 15.06
  • 52 Week Low
  • BLCO $13.16
  • ESNT $50.66
  • 52 Week High
  • BLCO $21.69
  • ESNT $65.33
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 36.81
  • ESNT 34.02
  • Support Level
  • BLCO $17.71
  • ESNT $52.22
  • Resistance Level
  • BLCO $18.99
  • ESNT $55.95
  • Average True Range (ATR)
  • BLCO 0.52
  • ESNT 1.10
  • MACD
  • BLCO -0.17
  • ESNT -0.20
  • Stochastic Oscillator
  • BLCO 10.17
  • ESNT 21.53

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About ESNT Essent Group Ltd.

Essent Group Ltd serves the housing finance industry by providing private mortgage insurance, reinsurance, risk management products and title insurance and settlement services to mortgage lenders, borrowers, and investors to support homeownership. It provides credit protection to lenders and mortgage investors by covering a portion of the unpaid principal balance of a mortgage and certain related expenses in the event of a default. By providing capital to mitigate mortgage credit risk, the company allows lenders to make additional mortgage financing available to prospective homeowners. Essent writes mortgage guaranty coverage in all 50 states and the District of Columbia.

Share on Social Networks: